News Alert: FDA, FTC warn 10 companies for making ‘fraudulent claims’ about unapproved diabetes supplements | Cardiovascular Business

Home

Recent Newsletters

CMS targets cardiologists | AI turns wearable data into insights | Heart failure after PCI | Prior authorization reducing access

FDA clears next-gen insulin pump | Key issues in EP | New-look valve makes US debut | The benefits of morning exercise

New PE guidelines | FDA clears 'world's smallest camera' | Medtronic's $550M acquisition | J&J launches 3 stroke devices

FDA approves first TAVR system for AR | AKI after TAVR | Injection could heal heart attack damage | Ultra-processed foods

News Alert: FDA approves first TAVR system for aortic regurgitation

AI gets value out of wearable data | Death sentence confirmed for patient-killing nurse | Tributes to a pioneer cardiologist

AI's growing influence in cardiology | New heart failure implant shows potential | FDA clears advanced technologies

Design by Adaptive Theme